Authors
Loading...
Systematic review demonstrates OCT biomarkers may indicate visual acuity outcomes in RVO patients, suggesting a pathway for improved treatment planning.
Hatamnejad et al. (2025) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: